Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs for Major Depressive Disorder
2 tracked Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs in the Major Depressive Disorder race. The class explanation lives on the Dopamine D2 and serotonin 5-HT2A receptors (antagonist) page; the full indication pipeline across every mechanism is on the Major Depressive Disorder page.
1 approved / phase 41 Phase 3
The roster
← all Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs